Global Parkinsons Disease Drug Market Insights and Forecast to 2028

Report ID: 1538407 | Published Date: Jan 2025 | No. of Page: 110 | Base Year: 2024 | Rating: 5 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Study Coverage
    1.1 Parkinsons Disease Drug Product Introduction
    1.2 Market by Type
        1.2.1 Global Parkinsons Disease Drug Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
        1.2.2 Carbidopa/Levodopa
        1.2.3 Dopamine Receptor Agonists
        1.2.4 MAO-Inhibitors
    1.3 Market by Application
        1.3.1 Global Parkinsons Disease Drug Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
        1.3.2 Hospital
        1.3.3 Clinics
        1.3.4 Other
    1.4 Study Objectives
    1.5 Years Considered
2 Executive Summary
    2.1 Global Parkinsons Disease Drug Sales Estimates and Forecasts 2017-2028
    2.2 Global Parkinsons Disease Drug Revenue Estimates and Forecasts 2017-2028
    2.3 Global Parkinsons Disease Drug Revenue by Region: 2017 VS 2021 VS 2028
    2.4 Global Parkinsons Disease Drug Sales by Region
        2.4.1 Global Parkinsons Disease Drug Sales by Region (2017-2022)
        2.4.2 Global Sales Parkinsons Disease Drug by Region (2023-2028)
    2.5 Global Parkinsons Disease Drug Revenue by Region
        2.5.1 Global Parkinsons Disease Drug Revenue by Region (2017-2022)
        2.5.2 Global Parkinsons Disease Drug Revenue by Region (2023-2028)
    2.6 North America
    2.7 Europe
    2.8 Asia-Pacific
    2.9 Latin America
    2.10 Middle East & Africa
3 Competition by Manufacturers
    3.1 Global Parkinsons Disease Drug Sales by Manufacturers
        3.1.1 Global Top Parkinsons Disease Drug Manufacturers by Sales (2017-2022)
        3.1.2 Global Parkinsons Disease Drug Sales Market Share by Manufacturers (2017-2022)
        3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Parkinsons Disease Drug in 2021
    3.2 Global Parkinsons Disease Drug Revenue by Manufacturers
        3.2.1 Global Parkinsons Disease Drug Revenue by Manufacturers (2017-2022)
        3.2.2 Global Parkinsons Disease Drug Revenue Market Share by Manufacturers (2017-2022)
        3.2.3 Global Top 10 and Top 5 Companies by Parkinsons Disease Drug Revenue in 2021
    3.3 Global Parkinsons Disease Drug Sales Price by Manufacturers (2017-2022)
    3.4 Analysis of Competitive Landscape
        3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Parkinsons Disease Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
        3.4.3 Global Parkinsons Disease Drug Manufacturers Geographical Distribution
    3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
    4.1 Global Parkinsons Disease Drug Sales by Type
        4.1.1 Global Parkinsons Disease Drug Historical Sales by Type (2017-2022)
        4.1.2 Global Parkinsons Disease Drug Forecasted Sales by Type (2023-2028)
        4.1.3 Global Parkinsons Disease Drug Sales Market Share by Type (2017-2028)
    4.2 Global Parkinsons Disease Drug Revenue by Type
        4.2.1 Global Parkinsons Disease Drug Historical Revenue by Type (2017-2022)
        4.2.2 Global Parkinsons Disease Drug Forecasted Revenue by Type (2023-2028)
        4.2.3 Global Parkinsons Disease Drug Revenue Market Share by Type (2017-2028)
    4.3 Global Parkinsons Disease Drug Price by Type
        4.3.1 Global Parkinsons Disease Drug Price by Type (2017-2022)
        4.3.2 Global Parkinsons Disease Drug Price Forecast by Type (2023-2028)
5 Market Size by Application
    5.1 Global Parkinsons Disease Drug Sales by Application
        5.1.1 Global Parkinsons Disease Drug Historical Sales by Application (2017-2022)
        5.1.2 Global Parkinsons Disease Drug Forecasted Sales by Application (2023-2028)
        5.1.3 Global Parkinsons Disease Drug Sales Market Share by Application (2017-2028)
    5.2 Global Parkinsons Disease Drug Revenue by Application
        5.2.1 Global Parkinsons Disease Drug Historical Revenue by Application (2017-2022)
        5.2.2 Global Parkinsons Disease Drug Forecasted Revenue by Application (2023-2028)
        5.2.3 Global Parkinsons Disease Drug Revenue Market Share by Application (2017-2028)
    5.3 Global Parkinsons Disease Drug Price by Application
        5.3.1 Global Parkinsons Disease Drug Price by Application (2017-2022)
        5.3.2 Global Parkinsons Disease Drug Price Forecast by Application (2023-2028)
6 North America
    6.1 North America Parkinsons Disease Drug Market Size by Type
        6.1.1 North America Parkinsons Disease Drug Sales by Type (2017-2028)
        6.1.2 North America Parkinsons Disease Drug Revenue by Type (2017-2028)
    6.2 North America Parkinsons Disease Drug Market Size by Application
        6.2.1 North America Parkinsons Disease Drug Sales by Application (2017-2028)
        6.2.2 North America Parkinsons Disease Drug Revenue by Application (2017-2028)
    6.3 North America Parkinsons Disease Drug Market Size by Country
        6.3.1 North America Parkinsons Disease Drug Sales by Country (2017-2028)
        6.3.2 North America Parkinsons Disease Drug Revenue by Country (2017-2028)
        6.3.3 U.S.
        6.3.4 Canada
7 Europe
    7.1 Europe Parkinsons Disease Drug Market Size by Type
        7.1.1 Europe Parkinsons Disease Drug Sales by Type (2017-2028)
        7.1.2 Europe Parkinsons Disease Drug Revenue by Type (2017-2028)
    7.2 Europe Parkinsons Disease Drug Market Size by Application
        7.2.1 Europe Parkinsons Disease Drug Sales by Application (2017-2028)
        7.2.2 Europe Parkinsons Disease Drug Revenue by Application (2017-2028)
    7.3 Europe Parkinsons Disease Drug Market Size by Country
        7.3.1 Europe Parkinsons Disease Drug Sales by Country (2017-2028)
        7.3.2 Europe Parkinsons Disease Drug Revenue by Country (2017-2028)
        7.3.3 Germany
        7.3.4 France
        7.3.5 U.K.
        7.3.6 Italy
        7.3.7 Russia
8 Asia Pacific
    8.1 Asia Pacific Parkinsons Disease Drug Market Size by Type
        8.1.1 Asia Pacific Parkinsons Disease Drug Sales by Type (2017-2028)
        8.1.2 Asia Pacific Parkinsons Disease Drug Revenue by Type (2017-2028)
    8.2 Asia Pacific Parkinsons Disease Drug Market Size by Application
        8.2.1 Asia Pacific Parkinsons Disease Drug Sales by Application (2017-2028)
        8.2.2 Asia Pacific Parkinsons Disease Drug Revenue by Application (2017-2028)
    8.3 Asia Pacific Parkinsons Disease Drug Market Size by Region
        8.3.1 Asia Pacific Parkinsons Disease Drug Sales by Region (2017-2028)
        8.3.2 Asia Pacific Parkinsons Disease Drug Revenue by Region (2017-2028)
        8.3.3 China
        8.3.4 Japan
        8.3.5 South Korea
        8.3.6 India
        8.3.7 Australia
        8.3.8 Taiwan
        8.3.9 Indonesia
        8.3.10 Thailand
        8.3.11 Malaysia
        8.3.12 Philippines
9 Latin America
    9.1 Latin America Parkinsons Disease Drug Market Size by Type
        9.1.1 Latin America Parkinsons Disease Drug Sales by Type (2017-2028)
        9.1.2 Latin America Parkinsons Disease Drug Revenue by Type (2017-2028)
    9.2 Latin America Parkinsons Disease Drug Market Size by Application
        9.2.1 Latin America Parkinsons Disease Drug Sales by Application (2017-2028)
        9.2.2 Latin America Parkinsons Disease Drug Revenue by Application (2017-2028)
    9.3 Latin America Parkinsons Disease Drug Market Size by Country
        9.3.1 Latin America Parkinsons Disease Drug Sales by Country (2017-2028)
        9.3.2 Latin America Parkinsons Disease Drug Revenue by Country (2017-2028)
        9.3.3 Mexico
        9.3.4 Brazil
        9.3.5 Argentina
10 Middle East and Africa
    10.1 Middle East and Africa Parkinsons Disease Drug Market Size by Type
        10.1.1 Middle East and Africa Parkinsons Disease Drug Sales by Type (2017-2028)
        10.1.2 Middle East and Africa Parkinsons Disease Drug Revenue by Type (2017-2028)
    10.2 Middle East and Africa Parkinsons Disease Drug Market Size by Application
        10.2.1 Middle East and Africa Parkinsons Disease Drug Sales by Application (2017-2028)
        10.2.2 Middle East and Africa Parkinsons Disease Drug Revenue by Application (2017-2028)
    10.3 Middle East and Africa Parkinsons Disease Drug Market Size by Country
        10.3.1 Middle East and Africa Parkinsons Disease Drug Sales by Country (2017-2028)
        10.3.2 Middle East and Africa Parkinsons Disease Drug Revenue by Country (2017-2028)
        10.3.3 Turkey
        10.3.4 Saudi Arabia
11 Company Profiles
    11.1 Teva
        11.1.1 Teva Corporation Information
        11.1.2 Teva Overview
        11.1.3 Teva Parkinsons Disease Drug Sales, Price, Revenue and Gross Margin (2017-2022)
        11.1.4 Teva Parkinsons Disease Drug Product Model Numbers, Pictures, Descriptions and Specifications
        11.1.5 Teva Recent Developments
    11.2 Novartis AG
        11.2.1 Novartis AG Corporation Information
        11.2.2 Novartis AG Overview
        11.2.3 Novartis AG Parkinsons Disease Drug Sales, Price, Revenue and Gross Margin (2017-2022)
        11.2.4 Novartis AG Parkinsons Disease Drug Product Model Numbers, Pictures, Descriptions and Specifications
        11.2.5 Novartis AG Recent Developments
    11.3 GSK
        11.3.1 GSK Corporation Information
        11.3.2 GSK Overview
        11.3.3 GSK Parkinsons Disease Drug Sales, Price, Revenue and Gross Margin (2017-2022)
        11.3.4 GSK Parkinsons Disease Drug Product Model Numbers, Pictures, Descriptions and Specifications
        11.3.5 GSK Recent Developments
    11.4 AbbVie
        11.4.1 AbbVie Corporation Information
        11.4.2 AbbVie Overview
        11.4.3 AbbVie Parkinsons Disease Drug Sales, Price, Revenue and Gross Margin (2017-2022)
        11.4.4 AbbVie Parkinsons Disease Drug Product Model Numbers, Pictures, Descriptions and Specifications
        11.4.5 AbbVie Recent Developments
    11.5 Merck
        11.5.1 Merck Corporation Information
        11.5.2 Merck Overview
        11.5.3 Merck Parkinsons Disease Drug Sales, Price, Revenue and Gross Margin (2017-2022)
        11.5.4 Merck Parkinsons Disease Drug Product Model Numbers, Pictures, Descriptions and Specifications
        11.5.5 Merck Recent Developments
    11.6 Boehringer Ingelheim
        11.6.1 Boehringer Ingelheim Corporation Information
        11.6.2 Boehringer Ingelheim Overview
        11.6.3 Boehringer Ingelheim Parkinsons Disease Drug Sales, Price, Revenue and Gross Margin (2017-2022)
        11.6.4 Boehringer Ingelheim Parkinsons Disease Drug Product Model Numbers, Pictures, Descriptions and Specifications
        11.6.5 Boehringer Ingelheim Recent Developments
    11.7 Impax Laboratories
        11.7.1 Impax Laboratories Corporation Information
        11.7.2 Impax Laboratories Overview
        11.7.3 Impax Laboratories Parkinsons Disease Drug Sales, Price, Revenue and Gross Margin (2017-2022)
        11.7.4 Impax Laboratories Parkinsons Disease Drug Product Model Numbers, Pictures, Descriptions and Specifications
        11.7.5 Impax Laboratories Recent Developments
    11.8 Lundbeck
        11.8.1 Lundbeck Corporation Information
        11.8.2 Lundbeck Overview
        11.8.3 Lundbeck Parkinsons Disease Drug Sales, Price, Revenue and Gross Margin (2017-2022)
        11.8.4 Lundbeck Parkinsons Disease Drug Product Model Numbers, Pictures, Descriptions and Specifications
        11.8.5 Lundbeck Recent Developments
    11.9 Sun Pharma
        11.9.1 Sun Pharma Corporation Information
        11.9.2 Sun Pharma Overview
        11.9.3 Sun Pharma Parkinsons Disease Drug Sales, Price, Revenue and Gross Margin (2017-2022)
        11.9.4 Sun Pharma Parkinsons Disease Drug Product Model Numbers, Pictures, Descriptions and Specifications
        11.9.5 Sun Pharma Recent Developments
    11.10 Wockhardt
        11.10.1 Wockhardt Corporation Information
        11.10.2 Wockhardt Overview
        11.10.3 Wockhardt Parkinsons Disease Drug Sales, Price, Revenue and Gross Margin (2017-2022)
        11.10.4 Wockhardt Parkinsons Disease Drug Product Model Numbers, Pictures, Descriptions and Specifications
        11.10.5 Wockhardt Recent Developments
    11.11 UCB
        11.11.1 UCB Corporation Information
        11.11.2 UCB Overview
        11.11.3 UCB Parkinsons Disease Drug Sales, Price, Revenue and Gross Margin (2017-2022)
        11.11.4 UCB Parkinsons Disease Drug Product Model Numbers, Pictures, Descriptions and Specifications
        11.11.5 UCB Recent Developments
    11.12 Bausch Health
        11.12.1 Bausch Health Corporation Information
        11.12.2 Bausch Health Overview
        11.12.3 Bausch Health Parkinsons Disease Drug Sales, Price, Revenue and Gross Margin (2017-2022)
        11.12.4 Bausch Health Parkinsons Disease Drug Product Model Numbers, Pictures, Descriptions and Specifications
        11.12.5 Bausch Health Recent Developments
    11.13 Acadia
        11.13.1 Acadia Corporation Information
        11.13.2 Acadia Overview
        11.13.3 Acadia Parkinsons Disease Drug Sales, Price, Revenue and Gross Margin (2017-2022)
        11.13.4 Acadia Parkinsons Disease Drug Product Model Numbers, Pictures, Descriptions and Specifications
        11.13.5 Acadia Recent Developments
12 Industry Chain and Sales Channels Analysis
    12.1 Parkinsons Disease Drug Industry Chain Analysis
    12.2 Parkinsons Disease Drug Key Raw Materials
        12.2.1 Key Raw Materials
        12.2.2 Raw Materials Key Suppliers
    12.3 Parkinsons Disease Drug Production Mode & Process
    12.4 Parkinsons Disease Drug Sales and Marketing
        12.4.1 Parkinsons Disease Drug Sales Channels
        12.4.2 Parkinsons Disease Drug Distributors
    12.5 Parkinsons Disease Drug Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
    13.1 Parkinsons Disease Drug Industry Trends
    13.2 Parkinsons Disease Drug Market Drivers
    13.3 Parkinsons Disease Drug Market Challenges
    13.4 Parkinsons Disease Drug Market Restraints
14 Key Findings in The Global Parkinsons Disease Drug Study
15 Appendix
    15.1 Research Methodology
        15.1.1 Methodology/Research Approach
        15.1.2 Data Source
    15.2 Author Details
    15.3 Disclaimer

List of Tables
    Table 1. Global Parkinsons Disease Drug Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
    Table 2. Major Manufacturers of Carbidopa/Levodopa
    Table 3. Major Manufacturers of Dopamine Receptor Agonists
    Table 4. Major Manufacturers of MAO-Inhibitors
    Table 5. Global Parkinsons Disease Drug Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
    Table 6. Global Parkinsons Disease Drug Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
    Table 7. Global Parkinsons Disease Drug Sales by Region (2017-2022) & (K Doses)
    Table 8. Global Parkinsons Disease Drug Sales Market Share by Region (2017-2022)
    Table 9. Global Parkinsons Disease Drug Sales by Region (2023-2028) & (K Doses)
    Table 10. Global Parkinsons Disease Drug Sales Market Share by Region (2023-2028)
    Table 11. Global Parkinsons Disease Drug Revenue by Region (2017-2022) & (US$ Million)
    Table 12. Global Parkinsons Disease Drug Revenue Market Share by Region (2017-2022)
    Table 13. Global Parkinsons Disease Drug Revenue by Region (2023-2028) & (US$ Million)
    Table 14. Global Parkinsons Disease Drug Revenue Market Share by Region (2023-2028)
    Table 15. Global Parkinsons Disease Drug Sales by Manufacturers (2017-2022) & (K Doses)
    Table 16. Global Parkinsons Disease Drug Sales Share by Manufacturers (2017-2022)
    Table 17. Global Parkinsons Disease Drug Revenue by Manufacturers (2017-2022) & (US$ Million)
    Table 18. Global Parkinsons Disease Drug Revenue Share by Manufacturers (2017-2022)
    Table 19. Parkinsons Disease Drug Price by Manufacturers (2017-2022) &(USD/Dose)
    Table 20. Global Parkinsons Disease Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 21. Global Parkinsons Disease Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Parkinsons Disease Drug as of 2021)
    Table 22. Parkinsons Disease Drug Manufacturing Base Distribution and Headquarters
    Table 23. Manufacturers Parkinsons Disease Drug Product Offered
    Table 24. Date of Manufacturers Enter into Parkinsons Disease Drug Market
    Table 25. Mergers & Acquisitions, Expansion Plans
    Table 26. Global Parkinsons Disease Drug Sales by Type (2017-2022) & (K Doses)
    Table 27. Global Parkinsons Disease Drug Sales by Type (2023-2028) & (K Doses)
    Table 28. Global Parkinsons Disease Drug Sales Share by Type (2017-2022)
    Table 29. Global Parkinsons Disease Drug Sales Share by Type (2023-2028)
    Table 30. Global Parkinsons Disease Drug Revenue by Type (2017-2022) & (US$ Million)
    Table 31. Global Parkinsons Disease Drug Revenue by Type (2023-2028) & (US$ Million)
    Table 32. Global Parkinsons Disease Drug Revenue Share by Type (2017-2022)
    Table 33. Global Parkinsons Disease Drug Revenue Share by Type (2023-2028)
    Table 34. Parkinsons Disease Drug Price by Type (2017-2022) & (USD/Dose)
    Table 35. Global Parkinsons Disease Drug Price Forecast by Type (2023-2028) & (USD/Dose)
    Table 36. Global Parkinsons Disease Drug Sales by Application (2017-2022) & (K Doses)
    Table 37. Global Parkinsons Disease Drug Sales by Application (2023-2028) & (K Doses)
    Table 38. Global Parkinsons Disease Drug Sales Share by Application (2017-2022)
    Table 39. Global Parkinsons Disease Drug Sales Share by Application (2023-2028)
    Table 40. Global Parkinsons Disease Drug Revenue by Application (2017-2022) & (US$ Million)
    Table 41. Global Parkinsons Disease Drug Revenue by Application (2023-2028) & (US$ Million)
    Table 42. Global Parkinsons Disease Drug Revenue Share by Application (2017-2022)
    Table 43. Global Parkinsons Disease Drug Revenue Share by Application (2023-2028)
    Table 44. Parkinsons Disease Drug Price by Application (2017-2022) & (USD/Dose)
    Table 45. Global Parkinsons Disease Drug Price Forecast by Application (2023-2028) & (USD/Dose)
    Table 46. North America Parkinsons Disease Drug Sales by Type (2017-2022) & (K Doses)
    Table 47. North America Parkinsons Disease Drug Sales by Type (2023-2028) & (K Doses)
    Table 48. North America Parkinsons Disease Drug Revenue by Type (2017-2022) & (US$ Million)
    Table 49. North America Parkinsons Disease Drug Revenue by Type (2023-2028) & (US$ Million)
    Table 50. North America Parkinsons Disease Drug Sales by Application (2017-2022) & (K Doses)
    Table 51. North America Parkinsons Disease Drug Sales by Application (2023-2028) & (K Doses)
    Table 52. North America Parkinsons Disease Drug Revenue by Application (2017-2022) & (US$ Million)
    Table 53. North America Parkinsons Disease Drug Revenue by Application (2023-2028) & (US$ Million)
    Table 54. North America Parkinsons Disease Drug Sales by Country (2017-2022) & (K Doses)
    Table 55. North America Parkinsons Disease Drug Sales by Country (2023-2028) & (K Doses)
    Table 56. North America Parkinsons Disease Drug Revenue by Country (2017-2022) & (US$ Million)
    Table 57. North America Parkinsons Disease Drug Revenue by Country (2023-2028) & (US$ Million)
    Table 58. Europe Parkinsons Disease Drug Sales by Type (2017-2022) & (K Doses)
    Table 59. Europe Parkinsons Disease Drug Sales by Type (2023-2028) & (K Doses)
    Table 60. Europe Parkinsons Disease Drug Revenue by Type (2017-2022) & (US$ Million)
    Table 61. Europe Parkinsons Disease Drug Revenue by Type (2023-2028) & (US$ Million)
    Table 62. Europe Parkinsons Disease Drug Sales by Application (2017-2022) & (K Doses)
    Table 63. Europe Parkinsons Disease Drug Sales by Application (2023-2028) & (K Doses)
    Table 64. Europe Parkinsons Disease Drug Revenue by Application (2017-2022) & (US$ Million)
    Table 65. Europe Parkinsons Disease Drug Revenue by Application (2023-2028) & (US$ Million)
    Table 66. Europe Parkinsons Disease Drug Sales by Country (2017-2022) & (K Doses)
    Table 67. Europe Parkinsons Disease Drug Sales by Country (2023-2028) & (K Doses)
    Table 68. Europe Parkinsons Disease Drug Revenue by Country (2017-2022) & (US$ Million)
    Table 69. Europe Parkinsons Disease Drug Revenue by Country (2023-2028) & (US$ Million)
    Table 70. Asia Pacific Parkinsons Disease Drug Sales by Type (2017-2022) & (K Doses)
    Table 71. Asia Pacific Parkinsons Disease Drug Sales by Type (2023-2028) & (K Doses)
    Table 72. Asia Pacific Parkinsons Disease Drug Revenue by Type (2017-2022) & (US$ Million)
    Table 73. Asia Pacific Parkinsons Disease Drug Revenue by Type (2023-2028) & (US$ Million)
    Table 74. Asia Pacific Parkinsons Disease Drug Sales by Application (2017-2022) & (K Doses)
    Table 75. Asia Pacific Parkinsons Disease Drug Sales by Application (2023-2028) & (K Doses)
    Table 76. Asia Pacific Parkinsons Disease Drug Revenue by Application (2017-2022) & (US$ Million)
    Table 77. Asia Pacific Parkinsons Disease Drug Revenue by Application (2023-2028) & (US$ Million)
    Table 78. Asia Pacific Parkinsons Disease Drug Sales by Region (2017-2022) & (K Doses)
    Table 79. Asia Pacific Parkinsons Disease Drug Sales by Region (2023-2028) & (K Doses)
    Table 80. Asia Pacific Parkinsons Disease Drug Revenue by Region (2017-2022) & (US$ Million)
    Table 81. Asia Pacific Parkinsons Disease Drug Revenue by Region (2023-2028) & (US$ Million)
    Table 82. Latin America Parkinsons Disease Drug Sales by Type (2017-2022) & (K Doses)
    Table 83. Latin America Parkinsons Disease Drug Sales by Type (2023-2028) & (K Doses)
    Table 84. Latin America Parkinsons Disease Drug Revenue by Type (2017-2022) & (US$ Million)
    Table 85. Latin America Parkinsons Disease Drug Revenue by Type (2023-2028) & (US$ Million)
    Table 86. Latin America Parkinsons Disease Drug Sales by Application (2017-2022) & (K Doses)
    Table 87. Latin America Parkinsons Disease Drug Sales by Application (2023-2028) & (K Doses)
    Table 88. Latin America Parkinsons Disease Drug Revenue by Application (2017-2022) & (US$ Million)
    Table 89. Latin America Parkinsons Disease Drug Revenue by Application (2023-2028) & (US$ Million)
    Table 90. Latin America Parkinsons Disease Drug Sales by Country (2017-2022) & (K Doses)
    Table 91. Latin America Parkinsons Disease Drug Sales by Country (2023-2028) & (K Doses)
    Table 92. Latin America Parkinsons Disease Drug Revenue by Country (2017-2022) & (US$ Million)
    Table 93. Latin America Parkinsons Disease Drug Revenue by Country (2023-2028) & (US$ Million)
    Table 94. Middle East and Africa Parkinsons Disease Drug Sales by Type (2017-2022) & (K Doses)
    Table 95. Middle East and Africa Parkinsons Disease Drug Sales by Type (2023-2028) & (K Doses)
    Table 96. Middle East and Africa Parkinsons Disease Drug Revenue by Type (2017-2022) & (US$ Million)
    Table 97. Middle East and Africa Parkinsons Disease Drug Revenue by Type (2023-2028) & (US$ Million)
    Table 98. Middle East and Africa Parkinsons Disease Drug Sales by Application (2017-2022) & (K Doses)
    Table 99. Middle East and Africa Parkinsons Disease Drug Sales by Application (2023-2028) & (K Doses)
    Table 100. Middle East and Africa Parkinsons Disease Drug Revenue by Application (2017-2022) & (US$ Million)
    Table 101. Middle East and Africa Parkinsons Disease Drug Revenue by Application (2023-2028) & (US$ Million)
    Table 102. Middle East and Africa Parkinsons Disease Drug Sales by Country (2017-2022) & (K Doses)
    Table 103. Middle East and Africa Parkinsons Disease Drug Sales by Country (2023-2028) & (K Doses)
    Table 104. Middle East and Africa Parkinsons Disease Drug Revenue by Country (2017-2022) & (US$ Million)
    Table 105. Middle East and Africa Parkinsons Disease Drug Revenue by Country (2023-2028) & (US$ Million)
    Table 106. Teva Corporation Information
    Table 107. Teva Description and Major Businesses
    Table 108. Teva Parkinsons Disease Drug Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
    Table 109. Teva Parkinsons Disease Drug Product Model Numbers, Pictures, Descriptions and Specifications
    Table 110. Teva Recent Developments
    Table 111. Novartis AG Corporation Information
    Table 112. Novartis AG Description and Major Businesses
    Table 113. Novartis AG Parkinsons Disease Drug Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
    Table 114. Novartis AG Parkinsons Disease Drug Product Model Numbers, Pictures, Descriptions and Specifications
    Table 115. Novartis AG Recent Developments
    Table 116. GSK Corporation Information
    Table 117. GSK Description and Major Businesses
    Table 118. GSK Parkinsons Disease Drug Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
    Table 119. GSK Parkinsons Disease Drug Product Model Numbers, Pictures, Descriptions and Specifications
    Table 120. GSK Recent Developments
    Table 121. AbbVie Corporation Information
    Table 122. AbbVie Description and Major Businesses
    Table 123. AbbVie Parkinsons Disease Drug Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
    Table 124. AbbVie Parkinsons Disease Drug Product Model Numbers, Pictures, Descriptions and Specifications
    Table 125. AbbVie Recent Developments
    Table 126. Merck Corporation Information
    Table 127. Merck Description and Major Businesses
    Table 128. Merck Parkinsons Disease Drug Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
    Table 129. Merck Parkinsons Disease Drug Product Model Numbers, Pictures, Descriptions and Specifications
    Table 130. Merck Recent Developments
    Table 131. Boehringer Ingelheim Corporation Information
    Table 132. Boehringer Ingelheim Description and Major Businesses
    Table 133. Boehringer Ingelheim Parkinsons Disease Drug Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
    Table 134. Boehringer Ingelheim Parkinsons Disease Drug Product Model Numbers, Pictures, Descriptions and Specifications
    Table 135. Boehringer Ingelheim Recent Developments
    Table 136. Impax Laboratories Corporation Information
    Table 137. Impax Laboratories Description and Major Businesses
    Table 138. Impax Laboratories Parkinsons Disease Drug Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
    Table 139. Impax Laboratories Parkinsons Disease Drug Product Model Numbers, Pictures, Descriptions and Specifications
    Table 140. Impax Laboratories Recent Developments
    Table 141. Lundbeck Corporation Information
    Table 142. Lundbeck Description and Major Businesses
    Table 143. Lundbeck Parkinsons Disease Drug Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
    Table 144. Lundbeck Parkinsons Disease Drug Product Model Numbers, Pictures, Descriptions and Specifications
    Table 145. Lundbeck Recent Developments
    Table 146. Sun Pharma Corporation Information
    Table 147. Sun Pharma Description and Major Businesses
    Table 148. Sun Pharma Parkinsons Disease Drug Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
    Table 149. Sun Pharma Parkinsons Disease Drug Product Model Numbers, Pictures, Descriptions and Specifications
    Table 150. Sun Pharma Recent Developments
    Table 151. Wockhardt Corporation Information
    Table 152. Wockhardt Description and Major Businesses
    Table 153. Wockhardt Parkinsons Disease Drug Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
    Table 154. Wockhardt Parkinsons Disease Drug Product Model Numbers, Pictures, Descriptions and Specifications
    Table 155. Wockhardt Recent Developments
    Table 156. UCB Corporation Information
    Table 157. UCB Description and Major Businesses
    Table 158. UCB Parkinsons Disease Drug Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
    Table 159. UCB Parkinsons Disease Drug Product Model Numbers, Pictures, Descriptions and Specifications
    Table 160. UCB Recent Developments
    Table 161. Bausch Health Corporation Information
    Table 162. Bausch Health Description and Major Businesses
    Table 163. Bausch Health Parkinsons Disease Drug Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
    Table 164. Bausch Health Parkinsons Disease Drug Product Model Numbers, Pictures, Descriptions and Specifications
    Table 165. Bausch Health Recent Developments
    Table 166. Acadia Corporation Information
    Table 167. Acadia Description and Major Businesses
    Table 168. Acadia Parkinsons Disease Drug Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
    Table 169. Acadia Parkinsons Disease Drug Product Model Numbers, Pictures, Descriptions and Specifications
    Table 170. Acadia Recent Developments
    Table 171. Key Raw Materials Lists
    Table 172. Raw Materials Key Suppliers Lists
    Table 173. Parkinsons Disease Drug Distributors List
    Table 174. Parkinsons Disease Drug Customers List
    Table 175. Parkinsons Disease Drug Market Trends
    Table 176. Parkinsons Disease Drug Market Drivers
    Table 177. Parkinsons Disease Drug Market Challenges
    Table 178. Parkinsons Disease Drug Market Restraints
    Table 179. Research Programs/Design for This Report
    Table 180. Key Data Information from Secondary Sources
    Table 181. Key Data Information from Primary Sources
List of Figures
    Figure 1. Parkinsons Disease Drug Product Picture
    Figure 3. Global Parkinsons Disease Drug Market Share by Type in 2021 & 2028
    Figure 3. Carbidopa/Levodopa Product Picture
    Figure 4. Dopamine Receptor Agonists Product Picture
    Figure 5. MAO-Inhibitors Product Picture
    Figure 6. Global Parkinsons Disease Drug Market Share by Application in 2021 & 2028
    Figure 7. Hospital
    Figure 8. Clinics
    Figure 9. Other
    Figure 10. Parkinsons Disease Drug Report Years Considered
    Figure 11. Global Parkinsons Disease Drug Sales 2017-2028 (K Doses)
    Figure 12. Global Parkinsons Disease Drug Revenue, (US$ Million), 2017 VS 2021 VS 2028
    Figure 13. Global Parkinsons Disease Drug Revenue 2017-2028 (US$ Million)
    Figure 14. Global Parkinsons Disease Drug Revenue Market Share by Region in Percentage: 2021 Versus 2028
    Figure 15. Global Parkinsons Disease Drug Sales Market Share by Region (2017-2022)
    Figure 16. Global Parkinsons Disease Drug Sales Market Share by Region (2023-2028)
    Figure 17. North America Parkinsons Disease Drug Sales YoY (2017-2028) & (K Doses)
    Figure 18. North America Parkinsons Disease Drug Revenue YoY (2017-2028) & (US$ Million)
    Figure 19. Europe Parkinsons Disease Drug Sales YoY (2017-2028) & (K Doses)
    Figure 20. Europe Parkinsons Disease Drug Revenue YoY (2017-2028) & (US$ Million)
    Figure 21. Asia-Pacific Parkinsons Disease Drug Sales YoY (2017-2028) & (K Doses)
    Figure 22. Asia-Pacific Parkinsons Disease Drug Revenue YoY (2017-2028) & (US$ Million)
    Figure 23. Latin America Parkinsons Disease Drug Sales YoY (2017-2028) & (K Doses)
    Figure 24. Latin America Parkinsons Disease Drug Revenue YoY (2017-2028) & (US$ Million)
    Figure 25. Middle East & Africa Parkinsons Disease Drug Sales YoY (2017-2028) & (K Doses)
    Figure 26. Middle East & Africa Parkinsons Disease Drug Revenue YoY (2017-2028) & (US$ Million)
    Figure 27. The Parkinsons Disease Drug Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
    Figure 28. The Top 5 and 10 Largest Manufacturers of Parkinsons Disease Drug in the World: Market Share by Parkinsons Disease Drug Revenue in 2021
    Figure 29. Global Parkinsons Disease Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
    Figure 30. Global Parkinsons Disease Drug Sales Market Share by Type (2017-2028)
    Figure 31. Global Parkinsons Disease Drug Revenue Market Share by Type (2017-2028)
    Figure 32. Global Parkinsons Disease Drug Sales Market Share by Application (2017-2028)
    Figure 33. Global Parkinsons Disease Drug Revenue Market Share by Application (2017-2028)
    Figure 34. North America Parkinsons Disease Drug Sales Market Share by Type (2017-2028)
    Figure 35. North America Parkinsons Disease Drug Revenue Market Share by Type (2017-2028)
    Figure 36. North America Parkinsons Disease Drug Sales Market Share by Application (2017-2028)
    Figure 37. North America Parkinsons Disease Drug Revenue Market Share by Application (2017-2028)
    Figure 38. North America Parkinsons Disease Drug Sales Share by Country (2017-2028)
    Figure 39. North America Parkinsons Disease Drug Revenue Share by Country (2017-2028)
    Figure 40. U.S. Parkinsons Disease Drug Revenue (2017-2028) & (US$ Million)
    Figure 41. Canada Parkinsons Disease Drug Revenue (2017-2028) & (US$ Million)
    Figure 42. Europe Parkinsons Disease Drug Sales Market Share by Type (2017-2028)
    Figure 43. Europe Parkinsons Disease Drug Revenue Market Share by Type (2017-2028)
    Figure 44. Europe Parkinsons Disease Drug Sales Market Share by Application (2017-2028)
    Figure 45. Europe Parkinsons Disease Drug Revenue Market Share by Application (2017-2028)
    Figure 46. Europe Parkinsons Disease Drug Sales Share by Country (2017-2028)
    Figure 47. Europe Parkinsons Disease Drug Revenue Share by Country (2017-2028)
    Figure 48. Germany Parkinsons Disease Drug Revenue (2017-2028) & (US$ Million)
    Figure 49. France Parkinsons Disease Drug Revenue (2017-2028) & (US$ Million)
    Figure 50. U.K. Parkinsons Disease Drug Revenue (2017-2028) & (US$ Million)
    Figure 51. Italy Parkinsons Disease Drug Revenue (2017-2028) & (US$ Million)
    Figure 52. Russia Parkinsons Disease Drug Revenue (2017-2028) & (US$ Million)
    Figure 53. Asia Pacific Parkinsons Disease Drug Sales Market Share by Type (2017-2028)
    Figure 54. Asia Pacific Parkinsons Disease Drug Revenue Market Share by Type (2017-2028)
    Figure 55. Asia Pacific Parkinsons Disease Drug Sales Market Share by Application (2017-2028)
    Figure 56. Asia Pacific Parkinsons Disease Drug Revenue Market Share by Application (2017-2028)
    Figure 57. Asia Pacific Parkinsons Disease Drug Sales Share by Region (2017-2028)
    Figure 58. Asia Pacific Parkinsons Disease Drug Revenue Share by Region (2017-2028)
    Figure 59. China Parkinsons Disease Drug Revenue (2017-2028) & (US$ Million)
    Figure 60. Japan Parkinsons Disease Drug Revenue (2017-2028) & (US$ Million)
    Figure 61. South Korea Parkinsons Disease Drug Revenue (2017-2028) & (US$ Million)
    Figure 62. India Parkinsons Disease Drug Revenue (2017-2028) & (US$ Million)
    Figure 63. Australia Parkinsons Disease Drug Revenue (2017-2028) & (US$ Million)
    Figure 64. Taiwan Parkinsons Disease Drug Revenue (2017-2028) & (US$ Million)
    Figure 65. Indonesia Parkinsons Disease Drug Revenue (2017-2028) & (US$ Million)
    Figure 66. Thailand Parkinsons Disease Drug Revenue (2017-2028) & (US$ Million)
    Figure 67. Malaysia Parkinsons Disease Drug Revenue (2017-2028) & (US$ Million)
    Figure 68. Philippines Parkinsons Disease Drug Revenue (2017-2028) & (US$ Million)
    Figure 69. Latin America Parkinsons Disease Drug Sales Market Share by Type (2017-2028)
    Figure 70. Latin America Parkinsons Disease Drug Revenue Market Share by Type (2017-2028)
    Figure 71. Latin America Parkinsons Disease Drug Sales Market Share by Application (2017-2028)
    Figure 72. Latin America Parkinsons Disease Drug Revenue Market Share by Application (2017-2028)
    Figure 73. Latin America Parkinsons Disease Drug Sales Share by Country (2017-2028)
    Figure 74. Latin America Parkinsons Disease Drug Revenue Share by Country (2017-2028)
    Figure 75. Mexico Parkinsons Disease Drug Revenue (2017-2028) & (US$ Million)
    Figure 76. Brazil Parkinsons Disease Drug Revenue (2017-2028) & (US$ Million)
    Figure 77. Argentina Parkinsons Disease Drug Revenue (2017-2028) & (US$ Million)
    Figure 78. Middle East and Africa Parkinsons Disease Drug Sales Market Share by Type (2017-2028)
    Figure 79. Middle East and Africa Parkinsons Disease Drug Revenue Market Share by Type (2017-2028)
    Figure 80. Middle East and Africa Parkinsons Disease Drug Sales Market Share by Application (2017-2028)
    Figure 81. Middle East and Africa Parkinsons Disease Drug Revenue Market Share by Application (2017-2028)
    Figure 82. Middle East and Africa Parkinsons Disease Drug Sales Share by Country (2017-2028)
    Figure 83. Middle East and Africa Parkinsons Disease Drug Revenue Share by Country (2017-2028)
    Figure 84. Turkey Parkinsons Disease Drug Revenue (2017-2028) & (US$ Million)
    Figure 85. Saudi Arabia Parkinsons Disease Drug Revenue (2017-2028) & (US$ Million)
    Figure 86. U.A.E Parkinsons Disease Drug Revenue (2017-2028) & (US$ Million)
    Figure 87. Parkinsons Disease Drug Value Chain
    Figure 88. Parkinsons Disease Drug Production Process
    Figure 89. Channels of Distribution
    Figure 90. Distributors Profiles
    Figure 91. Bottom-up and Top-down Approaches for This Report
    Figure 92. Data Triangulation
    Figure 93. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Teva
Novartis AG
GSK
AbbVie
Merck
Boehringer Ingelheim
Impax Laboratories
Lundbeck
Sun Pharma
Wockhardt
UCB
Bausch Health
Acadia
Frequently Asked Questions
Parkinsons Disease Drug report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Parkinsons Disease Drug report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Parkinsons Disease Drug report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Passive Optical LAN

Passive Optical LAN market is segmented by players, region (country), by Type and by Application. ... Read More

Patchouli Oil

Patchouli Oil market is segmented by Type and by Application. Players, stakeholders, and other pa ... Read More

Patent Medicine

Patent Medicine market is segmented by players, region (country), by Type and by Application. Pla ... Read More